Assessing Renal Risk in Type 2 Diabetes: Comparing Serum Age and Srage to Conventional Glycemic Markers
Annals of King Edward Medical University · 30.09.2026 · 32 (3) · 388-394
DOI: 10.21649/akemu.v32i3.6326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of King Edward Medical University, online erschienen am 30.09.2026. Verfasst von Saima Naz Mohsin und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetic nephropathy is a major complication of type 2 diabetes mellitus (T2DM) and a growing public health concern in Pakistan. Traditional glycemic markers such as HbA1c and fasting blood glucose (FBG) may not fully capture early renal risk. Advanced glycation end-products (AGEs) and soluble receptor for AGE (sRAGE) are emerging biomarkers reflecting cumulative glycemic burden, oxidative stress, and inflammatory pathways contributing to renal damage.
Objective
To assess associations of AGE and sRAGE with albuminuria in T2DM patients, and compare their predictive value with conventional glycemic markers.
Methods
In this cross-sectional study, 330 adults with T2DM attending Shaikh Zayed Hospital, Lahore, were evaluated. Clinical, demographic, and biochemical data including FBG, HbA1c, lipids, AGE, sRAGE, eGFR and albuminuria were collected. Associations were analyzed using Chi-square, Kruskal-Wallis tests, and multiple linear regressions for predictors of log-transformed ACR.
Results
AGE levels increased and sRAGE levels decreased as albuminuria worsened, leading to a higher AGE/sRAGE ratio (p < 0.001). Longer diabetes duration, hypertension, and obesity were also associated with higher albuminuria. FBG was a significant predictor of LN (ACR) (B = 0.003, p = 0.003), while HbA1c showed a marginal association (B = 0.075, p = 0.075). AGE (B = 0.051, p < 0.001) and sRAGE (p = 0.032) were stronger predictors of albuminuria than HbA1c. eGFR was a significant negative predictor (p < 0.001).
Conclusion
AGE and sRAGE provide a better indication of renal risk than conventional glycemic markers and may be useful for early detection and risk assessment. Including these biomarkers in routine diabetes care could help improve public health outcomes by identifying high-risk patients in Pakistan and preventing the progression of renal damage.
Zitieren
APA
Mohsin, S. N., Saleem, F., Muddassir, A., Bakhsh, A., Riaz, K., & Kashif-ur-Rehman (2026). Assessing Renal Risk in Type 2 Diabetes: Comparing Serum Age and Srage to Conventional Glycemic Markers. Annals of King Edward Medical University, 32(3), 388-394. https://doi.org/10.21649/akemu.v32i3.6326
Vancouver
Mohsin SN, Saleem F, Muddassir A, Bakhsh A, Riaz K, Kashif-ur-Rehman. Assessing Renal Risk in Type 2 Diabetes: Comparing Serum Age and Srage to Conventional Glycemic Markers. Annals of King Edward Medical University. 2026;32(3):388-394. doi:10.21649/akemu.v32i3.6326
BibTeX
@article{Mohsin2026,
author = {Mohsin, Saima Naz and Saleem, Faiza and Muddassir, Ambreen and Bakhsh, Ahmad and Riaz, Kashif and Kashif-ur-Rehman},
title = {Assessing Renal Risk in Type 2 Diabetes: Comparing Serum Age and Srage to Conventional Glycemic Markers},
journal = {Annals of King Edward Medical University},
year = {2026},
volume = {32},
number = {3},
pages = {388--394},
doi = {10.21649/akemu.v32i3.6326}
}
EUVIMED